Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots

Condition:   Deep Vein Thrombosis
Sponsors:   Dr. Vicky Tagalakis;   Sanofi
Not yet recruiting - verified April 2016

Study on the Incidence of Early Deep Vein Thrombosis After Peripherally Inserted Central Catheter Insertion

Condition:   Venous Thrombosis
Sponsor:   IRCCS Policlinico S. Matteo
Recruiting - verified April 2016

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses

Conditions:   Renal Insufficiency, Chronic;   Deep Venous Thrombosis, Protection Against
Intervention:   Drug: Tinzaparin
Sponsor:   Maisonneuve-Rosemont Hospital
Recruiting - verified April 2016

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Condition:   Venous Thromboembolism
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2016

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Conditions:   Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions:   Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
Sponsors:   Academic and Community Cancer Research United;   National Cancer Institute (NCI)
Recruiting - verified April 2016

Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty

Conditions:   Blood Loss;   Anatomic Total Shoulder Arthroplasty;   Reverse Total Shoulder Arthroplasty;   Transfusion;   Tranexamic Acid
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Rush University Medical Center
Recruiting - verified April 2016

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Condition:   Cancer
Interventions:   Drug: Rivaroxaban;   Drug: Placebo
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified April 2016

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified April 2016

Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.

Conditions:   Deep Vein Thrombosis;   Chronic Portal Vein Thrombosis
Intervention:   Drug: Xarelto
Sponsor:   Assistance Publique - Hôpitaux de Paris
Suspended - verified April 2016

Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System

Conditions:   Pulmonary Embolism;   Venous Thromboembolism;   Deep Vein Thrombosis
Sponsor:   Volcano Corporation
Withdrawn - verified December 2015

Doppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection

Condition:   Deep Venous Thrombosis
Sponsor:   Swanson Center
Recruiting - verified April 2016

Influence of Coffee Intake on Postoperative Bowel Function After Comprehensive Staging Surgery for Gynecological Malignancies: A Randomized Controlled Trial.

Condition:   Ilues
Interventions:   Dietary Supplement: caffe;   Dietary Supplement: Water
Sponsor:   Erzincan Military Hospital
Completed - verified November 2013

Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome

Conditions:   Deep Vein Thrombosis;   Post-thrombotic Syndrome
Interventions:   Device: compression stockings 25mm Hg;   Device: compression stockings 35 mm Hg
Sponsors:   Laboratoires Innothera;   University Hospital, Grenoble;   Floralis
Recruiting - verified April 2016

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Conditions:   Venous Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Tinzaparin
Sponsors:   St. Joseph's Healthcare Hamilton;   Heart and Stroke Foundation of Ontario;   LEO Pharma
Terminated - verified April 2016